SEQENS
Charlie (Chaicharn) S. currently serves as Managing Director of Consumer Healthcare at SEQENS since September 2018, previously holding the position of Quality Director in Essential Drug Substances. Prior experience includes various roles at Formulated Solutions from February 2013 to September 2017, culminating as Director of Quality, and a position as a Quality Control Specialist at Novartis from August 2011 to February 2013. Charlie holds a Bachelor of Science in Microbiology & Molecular Biology from the University of Central Florida and a Master of Public Health with a concentration in Infectious Diseases from Johns Hopkins Bloomberg School of Public Health. Additional academic credentials include multiple specialized certificates from Harvard Business School Online and participation in the Oxford Senior Executive Leadership Programme at Saïd Business School, University of Oxford, which is currently in progress.
This person is not in any offices
SEQENS
SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1.4 MM€ and operates 24 manufacturing plants and 10 R&D centers in Europe, North America and Asia. 3,400 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.